SPY415.21-2.05 -0.49%
DIA340.75-1.11 -0.32%
IXIC13,914.77-137.58 -0.98%

Organogenesis Holdings Q4 EPS $0.15 Beats $0.13 Estimate, Sales $106.80M Beat $99.18M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.13 by 15.38 percent. This is a 475 percent increase over losses of $(0.04) per share

· 03/16/2021 16:11
Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.13 by 15.38 percent. This is a 475 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $106.80 million which beat the analyst consensus estimate of $99.18 million by 7.68 percent. This is a 43.08 percent increase over sales of $74.64 million the same period last year.